Market Overview:
The global gonorrhea testing market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The growth of the market can be attributed to the increasing incidence of gonorrhea, rising awareness about sexually transmitted diseases (STDs), and technological advancements in gonorrhea testing methods. Based on type, the global gonorrhea testing market is segmented into nucleic acid amplification (NAA), gram stain, enzyme-linked immunosorbent assay (ELISA), gonorrhea culture, and rapid test. NAA is expected to be the fastest-growing segment during the forecast period owing to its high accuracy and sensitivity. Based on application, hospitals are expected to account for the largest share of the global gonorrhea testing market in 2018 followed by pathology labs.
Product Definition:
Gonorrhea is a sexually transmitted infection caused by the bacterium Neisseria gonorrhoeae. It can infect the genitals, rectum, and throat. Symptoms include pain when urinating, discharge from the penis or vagina, and swollen glands in the throat. Gonorrhea can be cured with antibiotics if it is caught early.
Nucleic Acid Amplification (NAA):
Nucleic acid amplification is a process by which the DNA or RNA of an infected person can be made to copy itself many times, resulting in increased concentration of the infecting organism. This test is used for detecting gonorrhea and other related infections. The nucleic acid amplification tests (NAATs) are divided into two types: direct NAAT and indirect NAAT.
Gram Stain:
Gram stain is a method used to detect the presence of bacteria in a sample. Gram stain procedure involves the use of acid and Country Gram (RC) media, which are used to grow gram-positive and gram-negative bacteria. The appearance of these bacterial species can then be observed under a microscope for identification purposes.
Application Insights:
The market is segmented based on the application as hospitals and pathology labs. Hospitals held the largest share of over 70% in 2017. The major factor contributing to this large share is that most of the population gets diagnosed through laboratory tests at a hospital, rather than a private lab. In addition, there are more opportunities for testing in case of complicated cases at hospitals due to availability of advanced diagnostic equipment such as automated microscopes and bio-hazardous waste management systems compared to other settings.
Gonorrhea culture test accounted for a significant share in 2017 owing to its low cost.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to increasing awareness about sexually transmitted diseases, rising prevalence of HIV, and growing number of government initiatives. For instance, in 2014 CDC launched a Gonorrhea Control & Prevention (GCP) initiative to control this disease which is one of the major causes for rare sexuel infections in U.S.
Asia Pacific is expected to grow at a lucrative rate over the forecast period owing to high incidence rates and prevalence of HIV/AIDS and other STDs that contribute significantly toward increased morbidity and mortality rates especially among adolescents & young adults (AYA). Moreover, improving healthcare infrastructure along with rising awareness levels will boost revenue generation from this region during the forecast period.
Growth Factors:
- Increasing incidence of gonorrhea
- Growing demand for early diagnosis and treatment of gonorrhea
- Rising awareness about the benefits of early diagnosis and treatment of gonorrhea
- Technological advancements in gonorrhea testing methods
- Growing number of sexually active people
Scope Of The Report
Report Attributes
Report Details
Report Title
Gonorrhea Testing Market Research Report
By Type
Nucleic Acid Amplification (NAA), Gram Stain, Enzyme-linked immunosorbent assay (ELISA), Gonorrhea Culture, Rapid test
By Application
Hospitals, Pathology Lab
By Companies
Abbott Laboratories, Bayer, Merck, Agilent Technologies, Biomerieux, Danaher, Thermo Fisher Scientific, Abbott, DiaSorin, Bristol-Myers Squibb, F. Hoffmann-La Roche
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
160
Number of Tables & Figures
112
Customization Available
Yes, the report can be customized as per your need.
Global Gonorrhea Testing Market Report Segments:
The global Gonorrhea Testing market is segmented on the basis of:
Types
Nucleic Acid Amplification (NAA), Gram Stain, Enzyme-linked immunosorbent assay (ELISA), Gonorrhea Culture, Rapid test
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Pathology Lab
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Bayer
- Merck
- Agilent Technologies
- Biomerieux
- Danaher
- Thermo Fisher Scientific
- Abbott
- DiaSorin
- Bristol-Myers Squibb
- F. Hoffmann-La Roche
Highlights of The Gonorrhea Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Nucleic Acid Amplification (NAA)
- Gram Stain
- Enzyme-linked immunosorbent assay (ELISA)
- Gonorrhea Culture
- Rapid test
- By Application:
- Hospitals
- Pathology Lab
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Gonorrhea Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Gonorrhea testing is a way to determine if someone has gonorrhea. Gonorrhea is a sexually transmitted infection (STI) that can cause problems with your reproductive system. Testing for gonorrhea can help identify people who may have the infection and help prevent further spread of the disease.
Some of the key players operating in the gonorrhea testing market are Abbott Laboratories, Bayer, Merck, Agilent Technologies, Biomerieux, Danaher, Thermo Fisher Scientific, Abbott, DiaSorin, Bristol-Myers Squibb, F. Hoffmann-La Roche.
The gonorrhea testing market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Gonorrhea Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Gonorrhea Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Gonorrhea Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Gonorrhea Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Gonorrhea Testing Market Size & Forecast, 2018-2028
4.5.1 Gonorrhea Testing Market Size and Y-o-Y Growth
4.5.2 Gonorrhea Testing Market Absolute $ Opportunity
Chapter 5 Global Gonorrhea Testing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Gonorrhea Testing Market Size Forecast by Type
5.2.1 Nucleic Acid Amplification (NAA)
5.2.2 Gram Stain
5.2.3 Enzyme-linked immunosorbent assay (ELISA)
5.2.4 Gonorrhea Culture
5.2.5 Rapid test
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Gonorrhea Testing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Gonorrhea Testing Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Pathology Lab
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Gonorrhea Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Gonorrhea Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Gonorrhea Testing Analysis and Forecast
9.1 Introduction
9.2 North America Gonorrhea Testing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Gonorrhea Testing Market Size Forecast by Type
9.6.1 Nucleic Acid Amplification (NAA)
9.6.2 Gram Stain
9.6.3 Enzyme-linked immunosorbent assay (ELISA)
9.6.4 Gonorrhea Culture
9.6.5 Rapid test
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Gonorrhea Testing Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Pathology Lab
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Gonorrhea Testing Analysis and Forecast
10.1 Introduction
10.2 Europe Gonorrhea Testing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Gonorrhea Testing Market Size Forecast by Type
10.6.1 Nucleic Acid Amplification (NAA)
10.6.2 Gram Stain
10.6.3 Enzyme-linked immunosorbent assay (ELISA)
10.6.4 Gonorrhea Culture
10.6.5 Rapid test
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Gonorrhea Testing Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Pathology Lab
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Gonorrhea Testing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Gonorrhea Testing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Gonorrhea Testing Market Size Forecast by Type
11.6.1 Nucleic Acid Amplification (NAA)
11.6.2 Gram Stain
11.6.3 Enzyme-linked immunosorbent assay (ELISA)
11.6.4 Gonorrhea Culture
11.6.5 Rapid test
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Gonorrhea Testing Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Pathology Lab
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Gonorrhea Testing Analysis and Forecast
12.1 Introduction
12.2 Latin America Gonorrhea Testing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Gonorrhea Testing Market Size Forecast by Type
12.6.1 Nucleic Acid Amplification (NAA)
12.6.2 Gram Stain
12.6.3 Enzyme-linked immunosorbent assay (ELISA)
12.6.4 Gonorrhea Culture
12.6.5 Rapid test
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Gonorrhea Testing Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Pathology Lab
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Gonorrhea Testing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Gonorrhea Testing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Gonorrhea Testing Market Size Forecast by Type
13.6.1 Nucleic Acid Amplification (NAA)
13.6.2 Gram Stain
13.6.3 Enzyme-linked immunosorbent assay (ELISA)
13.6.4 Gonorrhea Culture
13.6.5 Rapid test
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Gonorrhea Testing Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Pathology Lab
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Gonorrhea Testing Market: Competitive Dashboard
14.2 Global Gonorrhea Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.2 Bayer
14.3.3 Merck
14.3.4 Agilent Technologies
14.3.5 Biomerieux
14.3.6 Danaher
14.3.7 Thermo Fisher Scientific
14.3.8 Abbott
14.3.9 DiaSorin
14.3.10 Bristol-Myers Squibb
14.3.11 F. Hoffmann-La Roche
